Increase Life Expectancy with the Use of Pancreatic Cancer Therapeutics

Global Pancreatic Cancer Therapeutics Market was worth $ 2.08 billion in 2016 and estimated to be growing at a CAGR of 7.54%, to reach $2.99 billion by 2021.


Hyderabad, India -- (SBWire) -- 03/02/2018 --Pancreatic cancer begins in the tissues of duct gland. Duct gland releases enzymes that aid digestion and hormones that facilitate manage your blood glucose. Pancreatic cancer usually spreads quickly to nearby organs and rarely detected in its early stages. Except for individuals with exocrine gland cysts or a case history of carcinoma, some screening steps would possibly facilitate discovery of this disease early.

View Sample Report:

The global pancreatic cancer therapeutics market value is evaluated to be USD 2.08 billion in 2016 and is estimated to reach USD 3.01 billion by 2021 at a CAGR of 7.54%.
Factors corresponding to high unmet therapeutic desires within the overall medicine market, growing cancer issues across the globe, and new developments in the field of treatment area are likely to propel the expansion of the worldwide pancreatic cancer therapeutics market.

Read the full report:

However, technologies for the early detection of this cancer are still not available. Hence, a majority of patients with this disease are being diagnosed at a much later stage of the illness. Within the advanced stage of this cancer, the treatment choices are low resulting in deaths limiting the expansion of the market. Estimates show that very few percentage of patients are diagnosed early enough to be treated with surgical procedures, drugs, and therapy.

Geographically, the market is categorised into North America, Latin America, Asia-pacific, Europe and Middle East & Africa. North America is expected to dominate the market globally owing to a high number of patients suffering from pancreatic cancer. Asia-pacific is expected to witness a major growth rate during the forecast period.

Customize report:

Some of the key players of Pancreatic cancer therapeutics market include Eli Lilly, Amgen, Inc., Celgene Corp., F. Hoffmann-La Roche, Clovis Oncology Inc., Pfizer, Novartis AG, Threshold Pharmaceuticals Inc., Aduro BioTech Inc., Infinity Pharmaceuticals Inc. and NewLink Genetics Corp.

About MarketDataForecast™-
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.

Related reports:
Ovarian Cancer Therapeutics Market -
Uterine Cancer Therapeutics Market -

Contact Info:
Name: Mr. Abhishek Shukla
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626

Media Relations Contact

Sai Kutumbarao
Business Development Executive
Market Data Forecast

View this press release online at: